Essais liés6clinical trials
VilleBunkyō Citylocalisation
PaysJapanlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07843459

Ouvrir le site du centre

Essais cliniques associés

6
MoléculeIndication / populationPhaseNCTTitreStatut
LY3954068 Alzheimer Phase 1 NCT06297590 A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease RECRUITING
Efgartigimod PH20 SC Myopathies Phase 3 NCT05979441 ALKIVIA+ — A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy ENROLLING_BY_INVITATION
LY4560736 Alzheimer Phase 1 NCT07843459 A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) NOT_YET_RECRUITING
LY4405094 Alzheimer Phase 1 NCT07787169 A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease RECRUITING
LY4405094 Alzheimer Phase 1 NCT07787182 A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease RECRUITING
Cenerimod Lupus Phase 3 NCT05648500 OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus ACTIVE_NOT_RECRUITING